NOT-CA-14-036: Notice of Expiration of PAR-14-013 "Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21)"

Notice of Expiration of PAR-14-013 "Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21)"

Notice Number: NOT-CA-14-036

Key Dates
Release Date: March 28, 2014

Related Announcements
PAR-14-013

Issued by
National Cancer Institute (NCI)

Purpose

This Notice is to inform the scientific community that the National Cancer Institute (NCI) is terminating immediately PAR-14-013, "Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21)".

Applications will not be accepted in response to PAR-14-013. However, NCI intends to issue an updated FOA shortly.

Inquiries

Please direct all inquiries to:

Lori A. Henderson, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5930
Email: [email protected]